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Spontaneous reactivation of 
latent HIV-1 promoters is linked 
to the cell cycle as revealed by a 
genetic-insulators-containing dual-
fluorescence HIV-1-based vector
Yik Lim Kok1,2, Stefan Schmutz2, Anne Inderbitzin1,2,3, Kathrin Neumann1,2, 
Audrey Kelley1,2,3, Lisa Jörimann1,2, Mohaned Shilaih1,2, Valentina Vongrad1,2, 
Roger D. Kouyos1,2, Huldrych F. Günthard  1,2, Christian Berens  4 & Karin J. Metzner1,2
Long-lived latently HIV-1-infected cells represent a barrier to cure. We developed a dual-fluorescence 
HIV-1-based vector containing a pair of genetic insulators flanking a constitutive fluorescent reporter 
gene to study HIV-1 latency. The protective effects of these genetic insulators are demonstrated 
through long-term (up to 394 days) stable fluorescence profiles in transduced SUP-T1 cells. Analysis 
of 1,941 vector integration sites confirmed reproduction of HIV-1 integration patterns. We sorted 
monoclonal cells representing latent HIV-1 infections and found that both vector integration sites 
and integrity of the vector genomes influence the reactivation potentials of latent HIV-1 promoters. 
Interestingly, some latent monoclonal cells exhibited a small cell subpopulation with a spontaneously 
reactivated HIV-1 promoter. Higher expression levels of genes involved in cell cycle progression are 
observed in these cell subpopulations compared to their counterparts with HIV-1 promoters that 
remained latent. Consistently, larger fractions of spontaneously reactivated cells are in the S and G2 
phases of the cell cycle. Furthermore, genistein and nocodazole treatments of these cell clones, which 
halted cells in the G2 phase, resulted in a 1.4–2.9-fold increase in spontaneous reactivation. Taken 
together, our HIV-1 latency model reveals that the spontaneous reactivation of latent HIV-1 promoters 
is linked to the cell cycle.
Upon entry into a CD4+ T cell, the human immunodeficiency virus type 1 (HIV-1) integrates its reverse- 
transcribed viral DNA into the host’s genome1. The integrated provirus has two fates: it either continues its rep-
lication cycle to produce progeny virions or remains latent in the host cell1. The latent HIV-1 reservoir is unsus-
ceptible to both the host individual’s immune system and antiretroviral therapy (ART), which is currently only 
effective against active infections2. More importantly, ART cessation leads to rebound of HIV-1, thus necessitating 
lifelong therapy3.
Studies examining features driving the establishment and maintenance of HIV-1 latency have been limited 
by the low frequencies of cells latently infected with replication-competent HIV-1 in patients (~1–102 per 106 
CD4+ T cells)4,5 and the lack of phenotypic markers to identify these cells6. To circumvent these obstacles, in vitro 
models were developed to recapitulate HIV-1 infection and latency. Earlier models used HIV-1-based vectors 
encoding one fluorescent reporter gene to transduce and subsequently identify cells harbouring an active or latent 
HIV-1 promoter, i.e., those which expressed the fluorescent reporter gene constitutively or only when activated 
externally, respectively7–9. Dual-fluorescence vectors were later developed to identify cells harbouring a latent 
HIV-1 promoter without the need for external activation10–12. These second generation vectors have an additional 
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fluorescent reporter gene whose expression is driven by a constitutive promoter to identify transduced cells irre-
spective of their HIV-1 promoter activity.
These models have proved to be valuable in understanding molecular features of HIV-1 latency. For instance, 
it has been shown that vector integration sites have an influence on the HIV-1 promoter activity7,13,14, and 
Dahabieh et al. showed that the HIV-1 promoter activity correlates with the degree of activation of cells during 
transduction11. Sherrill-Mix et al. recently showed that the association between HIV-1 latency and chromosomal 
position is model dependent15. This is likely a consequence of the heterogeneous nature of the latent HIV-1 reser-
voir16, thus arguing for novel models to complement existing ones in order to unravel key determinants of HIV-1 
latency-associated events.
We have developed a novel HIV-1-based vector (LTatC[M]) consisting of two fluorescent reporter gene cas-
settes: Cerulean and mCherry (Fig. 1a). The expression of Cerulean is driven by the HIV-1 promoter in the viral 
5′ long terminal repeat (5′ LTR) and supported by the HIV-1 transactivator of transcription (Tat) via a positive 
feedback loop whereas the expression of mCherry is driven by the constitutive human elongation initiation fac-
tor 4A1 (heIF4A1) promoter (Fig. 1a). As such, Cerulean reports the activity of the HIV-1 promoter (active 
or latent) and mCherry labels transduced cells, enabling the identification of cells harbouring an active HIV-1 
promoter and simultaneously distinguishing cells harbouring a latent HIV-1 promoter from untransduced cells. 
Additionally, the mCherry cassette is flanked by a pair of genetic insulators, the chicken hypersensitive site 4 
core (cHS4) and synthetic matrix attachment region (sMAR) (Fig. 1a), to prevent (i) transcriptional interference 
between Cerulean and mCherry17–19 that might lead to artefactual HIV-1 latency and (ii) silencing of mCherry 
due to position-effect variegation20–25, thus ensuring its long-term constitutive expression.
In the present study, we first characterized our vector LTatC[M] and verified its capacity to reproduce features 
of active and latent HIV-1 infections. We then transduced SUP-T1 cells with LTatC[M] pseudotyped with vesic-
ular stomatitis virus glycoprotein G (VSV-G) and subsequently sorted out bulk cell populations, as well as mon-
oclonal cells, representing active and latent HIV-1 infections for further analysis. With our model, we observed 
that some monoclonal cells constantly exhibited a spontaneously reactivated HIV-1 promoter and found that this 
phenomenon is linked to the cell cycle.
Results
Transduction of SUP-T1 cells with LTatC[M] yields active and latent HIV-1 phenotypes. 
Transduction of SUP-T1 cells with VSV-G-pseudotyped LTatC[M] (Fig. 1a) yielded four cell populations: double 
positive (DP), single Cerulean positive (C+), single mCherry positive (M+), and double negative (DN) (Fig. 1b). 
The HIV-1 promoter in DP and C+ cells was active since Cerulean was expressed, and thus they represented 
active HIV-1 infections. Correspondingly, latent HIV-1 infections were represented by M+ cells due to their lack 
of Cerulean expression (Fig. 1b). Henceforth, DP and C+ will be called active and M+ will be called latent to 
denote the state of the HIV-1 promoter harboured in these cells and not of the host cells.
As we were interested in cell populations with stable phenotypes representing active and latent HIV-1 infec-
tions, we examined the kinetics of the emergence of the four cell populations: DP, C+, M+, and DN, for 10 days 
post transduction (Fig. 1c; Supplementary Fig. S1). The majority of transduced cells appeared to be latent up to 3 
days post transduction, although this phenomenon was transient, and a stable fluorescence profile for all trans-
duced cells was established only at 5 days post transduction. The initial fluctuations in fluorescence could be a 
result of differential temporal regulation of gene expression post integration at different vector integration sites 
and spontaneous reactivation of latent HIV-1 promoters in M+ cells. Similar kinetics were observed between 
transduction efficiencies of 5% and 15% (Fig. 1c; Supplementary Fig. S1). Therefore, we sorted with flow cytome-
try all four cell populations at 10 days post transduction with a purity of >99% for subsequent analyses (Fig. 1b).
Next, DN, C+, and M+ cell populations sorted from LTatC[M]-transduced SUP-T1 cells were treated with 
TNF-α and SAHA for 24 hours and the induction of DP cells from these cell populations was measured with flow 
cytometry. Approximately 7% of M+ cells expressed Cerulean and mCherry after induction with TNF-α and 
SAHA (Fig. 1d), showing that latent M+ cells could be activated to become double positive. The expression of 
either Cerulean or mCherry in DN cells and mCherry in C+ cells could not be induced with TNF-α and SAHA 
(Fig. 1d).
The genetic insulators, cHS4 and sMAR, confer long-term stability of fluorescence profiles in 
LTatC[M]-transduced SUP-T1 cells. The short-term kinetics and ratio of active (DP and C+) to latent 
cells (M+) were comparable between LTatC[M] and a vector variant with no genetic insulators flanking the 
mCherry cassette (LTatCM) (Supplementary Fig. S1), demonstrating that the genetic insulators did not influ-
ence the emergence of latent cells. As the present study focused on the long-term maintenance and persistence 
of HIV-1 latency, we examined whether the genetic insulators were capable of protecting the mCherry cassette 
from being silenced over time by monitoring the fluorescence profiles of the sorted DP, M+, and DN cell pop-
ulations transduced with LTatC[M] or LTatCM up to 191 days post transduction. Over 90% of cell populations 
transduced with LTatC[M] retained their initial fluorescence profiles for the entire period analysed (Fig. 2). In 
contrast, mCherry expression in DP cells transduced with LTatCM decreased gradually down to 48% at 191 days 
post transduction (Fig. 2a). The decrease in mCherry expression in LTatCM-transduced M+ cells was less drastic, 
although it remained consistently lower by ~5% compared to the LTatC[M]-transduced M+ cells (Fig. 2a). Our 
results were reproducible in a second transduction of SUP-T1 cells with LTatC[M]. Consistently, over 90% of all 
sorted cell populations in the second transduction retained their initial fluorescence profiles analysed for 394 
days post transduction (Fig. 2b). Therefore, the pair of genetic insulators, cHS4 and sMAR, flanking the mCherry 
cassette confer long-term protection to mCherry expression from silencing.
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LTatC[M] reproduces HIV-1 integration site patterns. To ensure that the genetic-insulators-containing 
LTatC[M] reproduced integration site patterns of HIV-1, vector integration sites from the sorted cell popula-
tions, DP, C+, MTSC+, MTSC−, and DN, were sequenced and mapped with the Integration Site Analysis Pipeline 
(InStAP)26. MTSC+ and MTSC− cells were sorted from latent M+ cells in which Cerulean expression was induci-
ble and non-inducible with TNF-α and SAHA, respectively (Fig. 1b). A total of 676 unique LTatC[M] integration 
sites were analysed. Across all cell populations, the majority of vector integration sites were found in transcription 
units, although slightly more in the inducible MTSC+ cells (Fig. 3a), and in a convergent transcriptional orien-
tation relative to vector-hosting genes, except for MTSC+ cells (Fig. 3c). The HIV-1 signature weakly conserved 
palindromic sequence was also observed at vector integration sites for all cell populations (Fig. 3b). These features 
were reproducible in a second transduction experiment in which a total of 1,265 unique vector integration sites 
were analysed (Supplementary Fig. S2).
Figure 1. Transduction of SUP-T1 cells with LTatC[M], a dual-fluorescence HIV-1-based vector. (a) Schematic 
diagram of LTatC[M]. The expression of Cerulean is driven by HIV-1 5′ long terminal repeat (LTR) and 
supported by HIV-1 transactivator of transcription (Tat) via a positive feedback loop. The expression of 
mCherry is driven by the constitutive human elongation initiation factor 4A1 (heIF4A1) promoter and the 
entire cassette is protected from position-effect variegation by a pair of genetic insulators: two copies of the 
chicken hypersensitive site 4 core (cHS4) and eight copies of synthetic matrix attachment region (sMAR). ψ: 
HIV-1 packaging signal; RRE; HIV-1 Rev response element; IRES: Internal ribosomal entry site; TetO: Tet 
operator; WPRE: Woodchuck hepatitis virus post-transcriptional regulatory element. (b) Flow cytometric 
sorting strategy and purity of transduced SUP-T1 cell populations. SUP-T1 cells transduced with LTatC[M] 
were sorted 10 days post transduction into four cell populations: single Cerulean positive (C+), double positive 
(DP), single mCherry positive (M+), and double negative (DN). DP cells were divided equally and cultured 
in two flasks. A portion of M+ cells was expanded in culture for 39 days and then activated with TNF-α and 
SAHA for one day prior to sorting into cell populations that became Cerulean+ (MTSC+) and that remained 
Cerulean− (MTSC−). (c) Fluorescence profiles of the four cell populations that arose from transduction of 
SUP-T1 cells with LTatC[M]: DN, M+, DP, and C+, were measured with flow cytometry daily for 10 days. 
Each datapoint represents the mean of two independent transductions (n = 2) and error bars depict standard 
error means. Some error bars are within datapoints. (d) DN, C+, and M+ cell populations sorted from 
LTatC[M]-tranduced SUP-T1 cells were treated with TNF-α and SAHA for one day and the induction of DP 
cells from these cell populations was measured with flow cytometry. In the case of DN cell population, the 
induction of C+ and M+ cells was also measured but not distinguished from DP cell induction. The means of 
two independent measurements (n = 2) are indicated by the heights of the bars and standard error means are 
indicated by the error bars.
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LTatC[M] integration site selection and genome integrity influence reactivation potentials of 
HIV-1 promoters in TNF-α and SAHA-responsive (MTSC+) and -non-responsive (MTSC−) single 
mCherry positive cell clones. The influence of HIV-1 integration sites on the reactivation potentials of 
latent HIV-1 promoters has been demonstrated previously7,13,14. To further explore this in our model, we sorted 
from latent cell populations (M+) from two transductions: 22 latent cell clones in which Cerulean expression 
was inducible with TNF-α and SAHA (MTSC+) and 18 latent cell clones in which Cerulean expression was 
non-inducible with TNF-α and SAHA (MTSC−), as well as 8 active cell clones (DP) (Fig. 1b). Vector integration 
sites were sequenced for all cell clones, and cell clones with identical vector integration sites were treated as bio-
logical replicates, resulting in 7 MTSC+, 13 MTSC−, and 6 DP independent cell clones.
We subsequently evaluated the reactivation potentials of latent HIV-1 promoters after expansion of MTSC+ 
and MTSC− cell clones in culture without TNF-α and SAHA, during which MTSC+ cell clones reverted to their 
initial phenotype of single mCherry positive. Surprisingly, highly variable reactivation potentials (26–89%) were 
observed among the seven MTSC+ cell clones with distinct vector integration sites (Fig. 4a; Table 1). To examine 
the effects of vector-hosting genes’ activity upon HIV-1 infection on the reactivation potentials of latent HIV-1 
Figure 2. Longitudinal fluorescence profiles of transduced SUP-T1 cell populations. (a) SUP-T1 cells were 
transduced with LTatC[M] (squares) or a vector variant with no genetic insulators in the mCherry cassette 
(LTatCM) (triangles). Double positive (DP), single mCherry positive (M+), and double negative (DN) cell 
populations were sorted 10 days post transduction and their fluorescence profiles were measured with flow 
cytometry for 191 days post transduction. Shaded symbols depict percentages of cells with the fluorescence 
initially sorted for whereas open symbols depict percentages of cells that became DN and M+. Each datapoint 
of the DP data set represents the mean of duplicate cultures (n = 2) and error bars depict standard error means. 
Some error bars are within datapoints. (b) Longitudinal fluorescence profiles of sorted SUP-T1 cell populations 
up to 394 days post transduction in a second transduction experiment.
www.nature.com/scientificreports/
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promoters, we used data from the Patterns of Expression and Analysis of Clusters of HIV/Host interactions 
(PEACHi) database27 (Fig. 4b). Data for MTSC1+3 (intergenic) and MTSC2+11 (CTNND1/TMX2-CTNND1) were 
not available on PEACHi. Of the five gene expression patterns for which data were available, EHBP1 (MTSC1+8), 
AKAP13 (MTSC1+12), P4HB (MTSC1+16), CDC42BPA (MTSC2+13), and RCOR1 (MTSC2+15), only P4HB was 
significantly downregulated (~8-fold; P<0.01) post HIV-1 integration, i.e. > 18 hours post infection27 (Fig. 4b). 
While this could explain why MTSC1+16 had a significantly lower reactivation potential than MTSC1+8 and 
MTSC1+15, it did not explain the much lower reactivation potentials of MTSC1+12 and MTSC2+13 since the 
vector-hosting genes in these cell clones were not significantly downregulated post HIV-1 integration (Fig. 4a,b).
Therefore, we examined the Cerulean cassettes of all cell clones to determine whether mutations contributed 
to low reactivation potentials of latent HIV-1 promoters. None (0/6) of the DP cell clones analysed had any 
mutations in their Cerulean cassettes whereas mutations were found in 5/7 MTSC+ cell clones (Fig. 5). Notably, 
MTSC1+12 had a mutation in the HIV-1 transactivation response (TAR) element, which was predicted to disrupt 
the 3-nucleotide bulge essential for HIV-1 Tat binding and subsequent transcription elongation from the HIV-1 
promoter28,29 (Fig. 4c), and MTSC2+13 had numerous mutations throughout its HIV-1 5′ LTR (Supplementary 
Table S1). Mutations in these cell clones could account for their low reactivation potentials. The mutations in the 
HIV-1 Tat region found in MTSC1+8 and MTSC1+16 (Fig. 5; Supplementary Table S1) have been reported to have 
wild-type transactivation activities30,31. Interestingly, no mutation was found in MTSC1+3 and MTSC2+15 while 
the reactivation potentials of latent HIV-1 promoters in these clones differed by ∼60% (Fig. 4a), further showing 
the influence of vector integration sites on the reactivation potentials of latent HIV-1 promoters. Taken together, 
our data provide evidence that the reactivation potentials of latent HIV-1 promoters are influenced by both vector 
integration sites and integrity of the Cerulean cassettes.
We then examined the Cerulean cassettes of the 18 MTSC− cell clones, the expression of which was not induc-
ible with TNF-α and SAHA. The Cerulean cassettes of 17/18 cell clones contained large internal deletions in the 
HIV-1 Tat and/or Cerulean region (Fig. 5). Although cell clone MT2-5 did not have internal deletions, multiple 
mutations were found throughout its Cerulean cassette (Fig. 5), e.g. one in the stem of HIV-1 TAR and another 
resulting in a C37Y amino acid substitution in HIV-1 Tat, which likely abolished transactivation by Tat28,29,31. 
Thus, defective vector genome is the main cause of non-inducible HIV-1 promoters in MTSC− cell clones. This 
phenomenon has also been observed in cells from HIV-1-infected individuals4.
Higher expression of a distinct set of cell cycle regulators in TNF-α and SAHA-responsive sin-
gle mCherry positive (MTSC+) cell subpopulations with spontaneously reactivated HIV-1 pro-
moters. Some MTSC+ cell clones when reverted to their initial M+ phenotype upon TNF-α and SAHA 
withdrawal, constantly exhibited a small subpopulation of cells with a spontaneously reactivated HIV-1 pro-
moter, i.e., cells that became double positive without further external stimulation. These spontaneous double 
positive cells are termed MspC+ while the majority of cells that remained single mCherry positive are termed 
MrC− here (Fig. 6a). To examine whether MspC+ and MrC− phenotypes were reversible, we sorted out the 
Figure 3. Integration site patterns of LTatC[M] in various SUP-T1 cell populations. (a) Genomic distributions 
of integrated LTatC[M]. (b) Consensus sequences of 20 nucleotides upstream of 5′LTR. Double negative (DN) is 
not shown due to low number of integration sites. (c) Transcription orientations of intragenic LTatC[M] relative 
to its host genes. DP1: double positive replicate 1; DP2: double positive replicate 2; C+: single Cerulean; MTSC+: 
TNF-α and SAHA-responsive single mCherry positive; MTSC−: TNF-α and SAHA-non-responsive single 
mCherry positive.
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two cell subpopulations respectively from five MTSC+ cell clones representing two distinct vector integration 
sites: MTSC1+8, MTSC1+28, and MTSC1+34 which had LTatC[M] integrated into EHBP1, and MTSC2+11 and 
MTSC2+20 which had LTatC[M] integrated into CTNND1 (Fig. 6a; Table 1). The percentages of spontaneous 
double positive cells that remained in the sorted MspC+ cell subpopulations and those that emerged from the 
sorted MrC− cell subpopulations over time were monitored with flow cytometry. For all MTSC+ cell clones, the 
majority of the sorted MspC+ cells became single mCherry positive while a small fraction of MrC− cells became 
double positive to the extents of their respective parental cell clones (Fig. 6c).
Given that the MspC+ and MrC− phenotypes were reversible, we hypothesized that the spontaneous reacti-
vation of HIV-1 promoters was linked to the cell cycle. The transcriptomes of MspC+ and MrC− cells at 0 day 
post sorting were sequenced to identify differentially expressed genes between the two cell subpopulations 
(Supplementary Fig. S3). Cells of the same fluorescence phenotype and vector integration site were treated as 
biological replicates. Using the cut-offs of fold change >1.5× (|log2ratio| > 0.585) and P < 0.02, we identified 18 
genes that had a higher expression level in MspC+ cell subpopulations compared to MrC− and were common 
between the two vector integration sites (Fig. 6b; Supplementary Table S2a). Of these 18 genes, three (16.7%) are 
Figure 4. Factors influencing reactivation potentials of latent HIV-1 promoters in TNF-α and SAHA-
responsive single mCherry positive (MTSC+) cell clones. (a) Reactivation potentials of latent HIV-1 promoters 
in TNF-α and SAHA-responsive single mCherry positive (MTSC+) cell clones with different LTatC[M] 
integration sites were reactivated with TNF-α and SAHA 54–106 days post sorting. The means of at least two 
independent measurements (n = 2–22) are indicated by the heights of the bars and standard error means are 
indicated by the error bars. Two-tailed Mann-Whitney U test with 95% confidence level was used to test for 
statistical significance; *P < 0.05; **P < 0.01. Subscripts 1 and 2 indicate two independent transduction and 
sorting experiments from which the cell clones were derived. DP: double positive. (b) Gene expression patterns 
in SUP-T1 cells during the first 24 hours upon infection with an HIV-1-based vector. Median log2 fold changes 
in expression of genes into which LTatC[M] was found integrated in different MTSC+ cell clones are shown. The 
majority of the HIV-1 integration process are defined as complete at 18 hours post infection. + and − indicate 
significant (P < 0.01) upregulation and downregulation in gene expression, respectively, whereas 0 indicates 
no significant changes in gene expression compared to data at time point 0 hour. Data were obtained from the 
Patterns of Expression and Analysis of Clusters of HIV/Host interactions (PEACHi) database27. Subscripts 1 and 
2 indicate two independent transduction and sorting experiments from which the cell clones were derived. (c) 
Predicted RNA secondary structure of HIV-1 transactivation response element. The RNA secondary structures 
of HIV-1 transactivation response (TAR) element found in cell clone MTSC1+12 (top) and in the original vector 
LTatC[M] (bottom) were predicted using CLC Main Workbench 7. Red circle indicates the mutation in the TAR 
element of MTSC1+12.
www.nature.com/scientificreports/
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known to promote cell cycle progression: FOSB, NEAT1, and EGR1 (Supplementary Table S2a). For instance, the 
two top hits, FOSB and NEAT1, have been reported to induce cell cycle entry by activating cyclin D1 in mouse 
fibroblasts32 and promote cell proliferation in cancer cells33, respectively. Furthermore, NEAT1 and EGR1 have 
also been reported to be involved in the HIV-1 replication cycle34,35. On the other hand, 86 genes were found 
Cell clone Integration locus Gene
Intragenic 
region
Transcriptional 
orientation
MTSC1+3 Chr3: 48710573 Intergenic N/A N/A
MTSC1+8 Chr2: 63216606 EHBP1 Intron 15/17* Convergent
MTSC1+12 Chr15: 86127496 AKAP13 Intron 7 Same
MTSC1+16 Chr17:79808805 P4HB Intron 4 Convergent
MTSC2+11 Chr11: 57536158 CTNND1/TMX2-CTNND1** Intron 1/2** Same
MTSC2+13 Chr1: 227375035 CDC42BPA Intron 5 Same
MTSC2+15 Chr14: 103178189 RCOR1 Intron 7 Same
Table 1. Integration sites of LTatC[M] in TNF-α and SAHA-responsive single mCherry positive (MTSC+) 
cell clones. Two other cell clones, MTSC1+28 and MTSC1+34, and another cell clone, MTSC2+20, which 
were included in subsequent analyses, had the same LTatC[M] integration site as MTSC1+8 and MTSC2+11, 
respectively. *Transcript variant; **TMX2-CTNND1 is read-through long non-coding RNA. Subscripts 1 and 2 
indicate two independent transduction and sorting experiments from which the clones were derived.
Figure 5. Mutational analysis of Cerulean cassettes of double positive (DP), TNF-α and SAHA-responsive 
single mCherry positive (MTSC+), and TNF-α and SAHA-non-responsive single mCherry positive (MTSC−) 
cell clones. Cerulean cassettes of double positive (DP), TNF-α and SAHA-responsive single mCherry positive 
(MTSC+), and TNF-α and SAHA-non-responsive single mCherry positive (MTSC−) cell clones were amplified 
and sequenced with the Illumina MiSeq next-generation sequencing technology. The schematic diagram of the 
LTatC[M] Cerulean cassette is shown on top and sequence coverages are depicted as yellow peaks with the range 
for each cell clone shown on the right. Point mutations are denoted by red asterisks. The numbers of cell clones 
with the same integration sites and mutation patterns analysed are shown next to the sequence coverage ranges. 
Subscripts 1 and 2 indicate two independent transduction and sorting experiments from which the cell clones 
were derived.
www.nature.com/scientificreports/
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to have a higher expression level in MrC− cell subpopulations (Fig. 6b; Supplementary Table S2b). Of these 86 
genes, 81 encode non-coding RNAs (Supplementary Table S2b), such as RN7SK, the RNA product of which 
sequesters CDK9 and CycT1 from acting as positive transcription elongation factors at the HIV-1 promoter36, 
and RN7SL1, RN7SL2, RNY1, and RNY3, which are cellular RNAs typically co-packaged in the HIV-1 viral par-
ticle37. Six (7.0%) and three (3.5%) of these 86 genes are known to promote and suppress cell cycle progression, 
respectively (Supplementary Table S2b).
Larger fractions of spontaneous double positive (MspC+) cells are in the S and G2 phases of the 
cell cycle compared to cells remaining as single mCherry positive (MrC−) and treatment with 
cell cycle regulators increased spontaneous reactivation. To further explore the linkage between 
spontaneous activation of latent HIV-1 promoters and the cell cycle, four MTSC+ cell clones representing two 
vector integration sites were resolved into G1, S, and G2 phases of the cell cycle by flow cytometric analysis 
of cells with their genomic DNA content fluorescently labelled. A significant increase in percentages of cells 
in the S (P < 0.05) and G2 (P < 0.001) phases of the cell cycle was observed in MspC+ cells in comparison to 
MrC− cells (Supplementary Fig. S4). The ratio of percentages of MspC+ cells to MrC− cells in each of the three 
cell cycle phases are shown in Fig. 7a. Consistently, treatment of these cell clones with genistein and nocodazole, 
which halted SUP-T1 cells in the G2 phase of the cell cycle (Supplementary Fig. S5), increased the percentages of 
Figure 6. Longitudinal fluorescence profiles of spontaneous double positive (MspC+) cell subpopulations and 
their counterparts that remained single mCherry positive (MrC−) sorted from TNF-α and SAHA-responsive 
single mCherry positive (MTSC+) cell clones. TNF-α and SAHA-responsive single mCherry positive (MTSC+) 
cell clones that exhibited a small subpopulation of spontaneous double positive (MspC+) cells without 
treatment with activators were sorted by flow cytometry for MspC+ cells and single mCherry cells that did 
not spontaneously become DP, i.e. non-spontaneous M+ (MrC−). (a) Representative flow cytometric sorting 
strategy and purity of MspC+ and MrC− cell subpopulations from MTSC1+8 cell clone. (b) Number of genes 
that had a higher expression level in MspC+ (top) and MrC− (bottom) cell subpopulations and were common 
between three MTSC+ cell clones with LTatC[M] integrated into EHBP1 and two MTSC+ cell clones with 
LTatC[M] integrated into CTNND1. (c) Longitudinal percentages of MspC+ cell subpopulations remaining 
and emerging from sorted MspC+ (shaded circles) and MrC− (open circles), respectively. Solid and dashed 
horizontal lines indicate the means and ranges of at least five independent measurements (n ≥ 5) of percentages 
of MspC+ cells in the unsorted parental cell clones. The top three cell clones had the same LTatC[M] integration 
site in EHBP1 whereas the bottom two cell clones had the same LTatC[M] integration site in CTNND1. 
Subscripts 1 and 2 indicate two independent transduction and sorting experiments from which the cell clones 
were derived.
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spontaneous reactivation by 1.8–2.1- and 1.4–2.9-fold, respectively (Fig. 7b). Taken together with the transcrip-
tomic data above, our findings suggest that spontaneous activation of latent HIV-1 promoters is linked to the cell 
cycle.
Discussion
HIV-1-based vectors have previously been utilized to dissect various aspects of HIV-1 infection7,10,11. In the pres-
ent study, we have developed a novel vector, LTatC[M], and characterized it in great detail with regard to its 
representation of HIV-1 infection and latency in SUP-T1 cells. In contrast to previous vectors, LTatC[M] con-
tains a pair of genetic insulators, cHS4 and sMAR, that flank the constitutive mCherry cassette to protect it from 
position-effect variegation that might be exerted at some integration sites7,38. Additionally, mCherry expression 
is driven by the human eIF4A1 promoter, which has been shown to yield high levels of gene expression in mac-
rophage cell lines39, potentially enabling the use of LTatC[M] to study HIV-1 infection in this other target cell 
type of HIV-1. Furthermore, cHS4 is capable of alleviating transcriptional interference between tandem gene 
cassettes17–19. The functionality of the genetic insulators was evident in two ways: (i) stable expression of Cerulean 
and/or mCherry in long-term bulk and monoclonal cell cultures for up to 394 days and (ii) absence of reactivat-
able HIV-1 and heIF4A1 promoters in the double negative cell population. In contrast, in a previous study using 
a dual-fluorescence vector without genetic insulators, a substantial fraction of double negative cells was found to 
harbour a reactivatable vector40. More importantly, these genetic insulators did not alter the kinetics and ratio of 
emergence of active and latent cells and vector integration site patterns compared to the control vector lacking 
the genetic insulators. With our model, we were able to examine HIV-1 latency in monoclonal cells with distinct 
vector integration sites. We focused on factors that contribute towards two aspects of HIV-1 latency reversal: (i) 
spontaneous reactivation and (ii) reactivation potentials upon external induction.
Spontaneous reactivation of latent HIV-1 promoters in vitro has also been observed by others7, although a 
mechanistic explanation is lacking. We found that spontaneous reactivation of latent HIV-1 promoters is linked 
to the cell cycle, as evidenced by transcriptomic profiling to identify differentially expressed genes between spon-
taneously reactivated and the remaining non-activated cell subpopulations within cell clones. This linkage was 
further corroborated by two observations: (i) larger fractions of spontaneously reactivated cells were in the S 
and G2 phases of the cell cycle compared to the non-activated cells and (ii) halting the cell cycle at the G2 phase 
with genistein and nocodazole increased the fraction of spontaneous reactivation. This is analogous to the partial 
reactivation of latent HIV-1 observed in central memory CD4+ T cells undergoing homeostatic proliferation41. 
Furthermore, viral production is known to increase in the G2 phase42,43. Interestingly, two cell cycle regulators 
having a higher expression level in spontaneously reactivated cells, NEAT1 and EGR1, have also been reported 
to be involved in the HIV-1 replication cycle. NEAT1 is essential for the formation of nuclear paraspeckles and 
has been found to be upregulated in peripheral blood mononuclear cells of untreated HIV-1-infected individuals 
(productive infection) compared to those of virally suppressed (latent infection)44. Additionally, knockdown of 
NEAT1 enhances HIV-1 production35. These studies suggest that NEAT1 might be upregulated as an antiviral 
response to HIV-1 expression, e.g. HIV-1 Tat in spontaneously reactivated cells. EGR1 encodes a transcriptional 
factor that regulates genes related to cell growth and differentiation. The expression of EGR1 is upregulated by 
HIV-1 Tat45,46 and its activation leads to the reversal of HIV-1 latency34, consistent with our observation that 
EGR1 was expressed more in spontaneously reactivated cells. The vast majority of genes identified to have a 
higher expression level in non-activated cells were non-coding small nuclear RNAs (snRNAs) with unknown 
relevance to HIV-1 infection, except for RN7SK, which forms an RNA scaffold that binds CDK9 and CycT1, thus 
sequestering these molecules from acting as a positive transcription elongation factor at the HIV-1 promoter36. 
The role of non-coding RNAs, especially long non-coding RNAs and microRNAs, in the modulation of HIV-1 
Figure 7. Spontaneous reactivation of latent HIV-1 promoters is linked to the cell cycle. (a) Ratio of 
percentages of cells in the various phases of the cell cycle in spontaneous double positive (MspC+) to non-
spontaneous M+ (MrC−) cell subpopulations. The means of at least four independent measurements (n ≥ 4) 
are indicated by the heights of the bars and standard error means are indicated by the error bars. (b) Percentages 
of MspC+ cells upon treatment with genistein (left) and nocodazole (right) in comparison to equally diluted 
DMSO control (−). The means of five independent measurements (n = 5) are indicated by the heights of the 
bars and standard error means are indicated by the error bars. Two-tailed Mann-Whitney U test with 95% 
confidence level was used to test for statistical significance; *P < 0.05; **P < 0.01. Subscripts 1 and 2 indicate 
two independent transduction and sorting experiments from which the cell clones were derived. MTSC+: 
TNF-α and SAHA-responsive single mCherry positive.
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infection is of great interest47,48 and snRNAs identified in our screen might represent an additional layer of poten-
tial candidates for further investigation in the context of HIV-1 latency establishment and maintenance.
The observations that larger fractions of spontaneously reactivated cells are in the later phases of the cell cycle 
and that spontaneous reactivation increased upon treatment with cell cycle regulators suggest that cell cycling 
might lead to spontaneous reactivation. This would provide a mechanistic explanation to the spontaneous reac-
tivation of latent HIV-1 proviruses observed in HIV-1-infected individuals during treatment interruption as a 
result of homeostatic proliferation of latently infected cells. Our model, however, does not exclude the alternative; 
cell cycling is a result of spontaneous reactivation. Spontaneous reactivation of latent HIV-1 proviruses has been 
described as an intrinsic characteristic of the virus49,50. We detected a higher expression of EGR1, which is a 
positive cell cycle regulator, in spontaneously reactivated cells and upregulation of EGR1 by HIV-1 Tat has been 
shown45,46. Tat is contained in our vector and it is an early-expressed gene in the HIV-1 replication cycle36. Thus, 
the intrinsic spontaneous reactivation of latent HIV-1 proviruses may drive cell cycling, potentially contribut-
ing towards clonal expansion of latently infected cells51–53. Of note, our minimalistic HIV-1-based vector does 
not encode, for example, HIV-1 Vpr, which is also known to modulate the host cell’s cell cycling programme54. 
Nonetheless, individual components of the viral genome could be cloned into our vector, thus enabling the pos-
sibility to systematically examine individual or combined effects of these components on cell cycling as well as 
other aspects of the host cell.
HIV-1 integration site selection has been implicated to have an influence on whether the integrated provirus 
would be active or latent, as well as the reactivation potentials of latent proviruses13,14. Vector integration sites 
identified in our model conformed to HIV-1 integration site patterns8,26,55–57. Furthermore, cells representing 
latent HIV-1 infections consistently exhibited different vector integration site patterns, albeit modest, than their 
active counterparts in two independent transductions; higher frequencies in transcription units and in the same 
transcriptional orientation relative to vector-hosting genes. These differences between active and latent cells were 
also reported in a primary-cell model transduced with HIV-1NL4–3 whose env was partially replaced with a flu-
orescent reporter gene58. More HIV-1 integrations in a convergent transcriptional orientation have also been 
observed in viraemic (active infections) than in treated (latent infections) individuals55. We further dissected 
cells with a latent HIV-1 phenotype into those that were inducible with TNF-α and SAHA to become active and 
those that were non-inducible. Inducible cell clones with distinct vector integration sites and expression profiles 
of vector-hosting genes displayed variable reactivation potentials. The reactivation potentials were dramatically 
attenuated in inducible cell clones with mutations in elements important for the expression of Cerulean, demon-
strating that the integrity of the viral genome, in addition to features of the viral integration site, has an impact on 
HIV-1 latency reversal. On the other hand, we did not find any non-inducible cell clone with an intact Cerulean 
cassette, although the sample size of cells analysed was relatively small. Major internal deletions and mutations, 
possibly a result of the error-prone HIV-1 reverse transcriptase59,60 and copy-choice recombination61,62, were 
the cause of these clones not being reactivatable. Such a phenomenon is also observed in cells derived from 
HIV-1-infected individuals4, although the rate and site of mutation and recombination are likely to differ in our 
system utilizing a minimalistic HIV-1-based vector. Nonetheless, our observation accentuates the need to care-
fully examine singly fluorescent cell populations, e.g. latency-representing cells, in HIV-1 latency models using 
HIV-1-based vector systems.
Besnard et al. recently, in a genome-wide shRNA screen, identified candidate genes that either promote or 
inhibit HIV-1 latency, and subsequently showed that the mechanistic target of rapamycin (mTOR) complex is a 
positive regulator of HIV-1 latency reversal63. In their screen, actin cytoskeleton reorganization pathways were 
also found to be potentially involved in the regulation of HIV-1 latency63. Interestingly, 4/7 inducible cell clones 
analysed had LTatC[M] integrated into genes related to actin cytoskeleton reorganization: EHBP164, AKAP1365, 
CTNND166, and CDC42BPA67. For example, EHBP1 links actin to the cell membrane for endosomal tubulation64 
and CDC42BPA (Cell division control 42 binding protein kinase α) (CDC42 effector protein 5 is the second high-
est latency-promoting gene in the study of Besnard et al.)63 promotes actin and myosin reorganization67. These 
four genes are also listed as latency promoting in the study of Besnard et al.63. The linkage between integration 
into these genes and HIV-1 latency establishment is currently unclear. Nevertheless, our observation comple-
ments current knowledge on HIV-1 latency and presents an interesting finding for further investigation.
Conclusions
In summary, our well-characterized dual-fluorescence, genetic-insulators-containing HIV-1-based vector is capa-
ble of recapitulating various facets of HIV-1 infection and latency and invariably maintains active and latent 
HIV-1 phenotypes over a long observation period spanning at least one year. Application of this vector might 
provide insights into the pathomechanisms of HIV-1 latency. We applied this vector to study spontaneous reac-
tivation of latent HIV-1 promoters in SUP-T1 cells and found a linkage between this phenomenon and the cell 
cycle. This is an important basis for further investigations on the mechanisms of maintenance of the HIV-1 reser-
voir and by which spontaneous viral rebound occurs in HIV-1-infected individuals off ART.
Methods
Plasmid vector construction. LTatC[M] was synthesized by GeneArt (Thermo Fisher Scientific), 
except that the HIV-1 Rev response element (RRE) was amplified and cloned from pEV7317 (kindly provided 
by Eric Verdin) with primer pair 5′NNNNNNGTCGACCTCGAGATGGGTGCGAGAGCGTCAG3′ and 
5′NNNNNNGTCGACGGTGGCATCGATACCGTCGAG3′, and the Woodchuck hepatitis virus post-transcrip-
tional regulatory element (WPRE) was amplified from pCLX-UBI-GFP (kindly provided by Patrick Salmon; 
Addgene plasmid # 27245) with primer pair 5′NNNNNNGGATCCCGATAATCAACCTCTGGATTAC3′ and 
5′NNNNNNACCGGTAATTCCCAGGCGGGGAGG3′. Genetic elements in LTatC[M] are shown in Fig. 1a and 
tabulated in Supplementary Table S3.
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Virus pseudotyping and titration. VSV-G-pseudotyped LTatC[M] were generated by transfecting 293 T 
cells (American Type Culture Collection) of at least 90% confluency cultured in DMEM (Sigma-Aldrich) supple-
mented with 10% (v/v) fetal bovine serum (FBS) (Thermo Fisher Scientific), 100 U/mL Penicillin, and 100 μg/mL 
Streptomycin (Thermo Fisher Scientific) in a T-150 flask with the following components: pLTatC[M] (20.8 μg), 
psPAX2 (20.8 μg) (kindly provided by Didier Trono; Addgene plasmid # 12260), pCAG-VSVG (10.4 μg) (kindly 
provided by Arthur Nienhuis and Patrick Salmon; Addgene plasmid # 35616), polyethylenimine (208 μg), and 
serum-free DMEM in a total volume of 3.4 mL. Medium was replaced 18 hours post transfection. Supernatant 
containing viral particles was harvested twice at 24 and 48 hours post medium change, and concentrated with 
PEG-it (System Biosciences) to a final volume of 450 μL.
VSV-G-pseudotyped virus stocks were titrated by transducing 0.2 million SUP-T1 cells68 (kindly provided 
by Dharam Ablashi through the NIH AIDS Reagent Programme, Division of AIDS, NIAID, NIH) cultured in 
200 μL of RPMI-1640 (Sigma-Aldrich) supplemented with 10% (v/v) FBS, 100 U/mL Penicillin, and 100 μg/mL 
Streptomycin in 48-well plates with virus stocks. Medium was replaced daily and cells were analysed with flow 
cytometry (BD Biosciences LSR Fortessa) for total positive cells, i.e., cells expressing mCherry and/or Cerulean, 
at 5 days post transduction. The mean viral titre was calculated from transductions that yielded a total positive 
cells of <20%, thus ensuring a high probability of obtaining single integrants per cell69, and expressed as SUP-T1 
transduction units/mL.
SUP-T1 transduction and flow cytometric sorting. SUP-T1 cells were transduced with VSV- 
pseudotyped LTatC[M] to yield 5–56% of positive cells. All four cell populations were sorted with flow cytom-
etry (BD Biosciences FACS ARIA III) 4–13 days post transduction. For sorting of tumour necrosis factor 
alpha (TNF-α) (Bio-Techne) and suberanilohydroxamic acid (SAHA) (Bio-Techne)-inducible (MTSC+) and 
-non-inducible (MTSC−) cell populations, M+ cells were treated with 0.01 μg/mL TNFα and 1 μM SAHA for 
24 hours prior to sorting.
Amplification, sequencing, and mapping of 5′ vector integration junctions. The 5′ vector inte-
gration junctions were amplified, sequenced, and mapped as described previously26. Briefly, 5′ vector integration 
junctions were amplified with the non-restrictive linear amplification-mediated PCR70 and 12–14 pM purified 
PCR products were sequenced with the Illumina MiSeq platform using the MiSeq Reagent Kit v2 (300 cycles) 
(Illumina) with 8% PhiX. Mapping of sequencing reads to the human genome assembly GRCh37.p13 was per-
formed using an in-house bioinformatic pipeline, Integration Site Analysis Pipeline (InStAP). All vector integra-
tion junctions are listed in Supplementary Table S4.
Amplification and sequencing of Cerulean cassettes. The Cerulean cassettes, spanning from the 
HIV-1 5′ LTR to cHS4, in transduced cells were amplified using Platinum Taq DNA polymerase high fidelity 
(Thermo Fisher Scientific) with the forward primer 5′GACAAGAGATCCTTGATCTGTGGATC3′ and reverse 
primer 5′CACTGATAGGGAGTAAACATATGC3′ or 5′GAAGGACAGCTTCAAGTAGTCG3′. The cycling con-
ditions were 94 °C for 2 min, 40 cycles of 94 °C for 30 s, 55 °C for 30 s and 68 °C for 5 min 30 s, and a final extension 
of 68 °C for 10 min.
The amplicons were processed with the Nextera XT DNA Library Preparation Kit (Illumina) and subsequently 
sequenced with the MiSeq reagent Kit v2 (50 cycles) with 1% PhiX.
Transcriptomic analysis. Total RNA was extracted using AllPrep DNA/RNA Kit (Qiagen) and 
reverse-transcribed library was prepared and normalized using SMARTer Stranded Total RNA-Seq Kit – Pico 
Input Mammalian (Takara). The TruSeq SR Cluster Kit v4-cBot-HS or TruSeq PE Cluster Kit v4-cBot-HS 
(Illumina) was used for cluster generation with 8 pM pooled normalized libraries on the Illumina cBOT system. 
Sequencing was performed with the Illumina HiSeq. 2500; paired end at 2 × 126 bp or single end 126 bp using the 
TruSeq SBS Kit v4-HS (Illumina).
Bioinformatic analysis was performed using the R package ezRun (https://github.com/uzh/ezRun) within 
the data analysis framework SUSHI71. Raw reads were quality checked using Fastqc (http://www.bioinformat-
ics.babraham.ac.uk/projects/fastqc/) and FastQ Screen (http://www.bioinformatics.babraham.ac.uk/projects/
fastq_screen/). Quality-controlled reads were aligned to the reference genome GRCh38 using the STAR aligner72. 
Expression counts were computed using featureCounts in the Bioconductor package Subread73. Differential 
expression analysis was performed using the edgeR package74, where raw read counts were normalized using the 
Trimmed Mean of M values (TMM) method75 and differential expression was computed using the Generalized 
Linear Mode (GLM) likelihood ratio test. Quality checkpoints76, such as quality control of the alignment and 
count results were implemented in ezRun and applied throughout the analysis workflow to ensure correct data 
interpretation.
Cell cycle analysis. A total of 1 million cells were fixed in 1 mL of 2% (w/v) paraformaldehyde (Fluka) in 
Dulbecco’s phosphate-buffered saline (DPBS) on ice for 15 min, washed with DPBS twice by centrifugation at 
800 g for 5 min, resuspended in 1 mL of 0.1% (v/v) Triton X-100 (Sigma-Aldrich) in DPBS supplemented with 1% 
(v/v) FBS, treated with 0.1 mg/mL RNase A (Thermo Fisher Scientific), and stained with 1 μL of FxCycle Far Red 
Stain (Thermo Fisher Scientific) at room temperature for 30 min. Cell cycle profiles were modeled with the Cell 
Cycle function in FlowJo v10.0.8 [Watson (Pragmatic); CV of G2 peak = CV of G1 peak].
Cell cycle regulators treatment. A total of 0.1 million MTSC+ cells cultured in 200 μL of RPMI-1640 
(10% (v/v) FBS, 100 U/mL Penicillin, and 100 μg/mL Streptomycin) or 1 million SUP-T1 cells cultured in 2 mL 
of RPMI-1640 (10% (v/v) FBS, 100 U/mL Penicillin, and 100 μg/mL Streptomycin) were treated with 30 μM 
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genistein (Selleckchem), 40 ng/mL nocodazole (Sigma-Aldrich), or equally diluted dimethyl sulfoxide (DMSO) 
(Sigma-Aldrich) for 24 hours prior to flow cytometric analysis.
Data availability. Data generated and analysed during this study are included in this published article and 
its supplementary information files unless stated otherwise, in which case are available from the corresponding 
author on reasonable request.
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